CNSX:BIO Bio-Rad Laboratories (BIO) Stock Price, News & Analysis → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free BIO Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume265,600 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Bio-Rad Laboratories alerts: Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Bio-Rad Laboratories Stock (CNSX:BIO)Biome Grow Inc. focuses on the cannabis business. Biome Grow Inc. is headquartered in Toronto, Canada.Read More Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. BIO Stock News HeadlinesApril 17, 2024 | finance.yahoo.comBio-Rad Laboratories (NYSE:BIO shareholders incur further losses as stock declines 14% this week, taking three-year losses to 53%April 14, 2024 | seekingalpha.comBio-Rad: A Lackluster Picks-And-Shovels Life Science Company With A Key Investment KickerApril 23, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. April 13, 2024 | finance.yahoo.comOncoCyte Corp (OCX) Q4 2023 Earnings Call Transcript Highlights: Strategic Partnerships and ...April 9, 2024 | markets.businessinsider.comRBC Capital Reaffirms Their Buy Rating on Bio-Rad Laboratories (BIO)March 25, 2024 | uk.finance.yahoo.comGlobal Blood Glucose Monitoring System Market Poised for Substantial Growth by 2030March 20, 2024 | markets.businessinsider.comBio-Rad Laboratories Appoints Roop Lakkaraju As EVP And CFOMarch 20, 2024 | businesswire.comBio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial OfficerApril 23, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. March 18, 2024 | finanznachrichten.deContinuous Bioprocessing Market Worth $1,067.8 Mn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.March 16, 2024 | finance.yahoo.comBIO Apr 2024 420.000 callMarch 16, 2024 | finance.yahoo.comBIO Apr 2024 185.000 putMarch 13, 2024 | theglobeandmail.comBlood Group Typing Market worth $3.0 billion by 2028 | MarketsandMarketsFebruary 22, 2024 | finance.yahoo.comBio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access DayFebruary 21, 2024 | finance.yahoo.comBIO Jun 2024 270.000 putFebruary 16, 2024 | msn.comREFILE-Bio Rad Labs rises after posting upbeat fourth-quarter profitFebruary 16, 2024 | finance.yahoo.comBio-Rad (BIO) Q4 Earnings Beat, Revenues Miss, Margins DownFebruary 16, 2024 | finance.yahoo.comBio-Rad Laboratories, Inc. (NYSE:BIO) Q4 2023 Earnings Call TranscriptFebruary 16, 2024 | finance.yahoo.comQ4 2023 Bio Rad Laboratories Inc Earnings CallFebruary 15, 2024 | reuters.comBio Rad Labs rises after posting upbeat fourth-quarter profitFebruary 15, 2024 | finance.yahoo.comBio-Rad Laboratories (BIO) Surpasses Q4 Earnings EstimatesFebruary 5, 2024 | finance.yahoo.comBio-Rad Laboratories (BIO) to Post Q4 Earnings: What Awaits?January 24, 2024 | finance.yahoo.comLab-on-a-Chip Market Forecasted to Reach $12.7 Billion by 2030 with Instruments Segment Leading the GrowthJanuary 24, 2024 | hk.finance.yahoo.comCancer Tissue Diagnostics Market Surges Towards US$11.1 Billion by 2030 with 6.9% CAGR | Persistence Market ResearchJanuary 19, 2024 | finance.yahoo.com3 Discounted MedTech Stocks Poised for Sturdy Growth in 2024January 8, 2024 | msn.comSPY ETF Update, 1/8/2024January 4, 2024 | finance.yahoo.comLiquid Biopsy Market Size Projected to Reach USD 7.7 billion by 2031, With 8.8% CAGR: Transparency Market Research, Inc.See More Headlines Receive BIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bio-Rad Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCNSX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCNSX:BIO CUSIPN/A CIKN/A Webwww.biomegrow.com Phone416-875-8395FaxN/AEmployees8,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Khurram Malik MBACEO, President & DirectorMr. Abbey Abdiye C.M.A. (Age 49)CPA, Chief Financial Officer Comp: $110.95kScott CuthbertsonVP of Investor RelationsMr. Frank MacMasterPresident of Highland Grow Inc.David CallahanPresident of The Back Home Medical Cannabis CorporationKey CompetitorsAbattis BioceuticalsCNSX:ATTAgraflora Organics InternationalCNSX:AGRAAmplify Alternative Harvest ETFCNSX:MJBlueberries MedicalCNSX:BBMBooksAMillionCNSX:BAMMView All Competitors BIO Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Bio-Rad Laboratories own? Based on aggregate information from My MarketBeat watchlists, some companies that other Bio-Rad Laboratories investors own include Cross Timbers Royalty Trust (CRT), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), Curaleaf (CURLF), Cannara Biotech (LOVE), Brigham Minerals (MNRL) and Arbor Realty Trust (ABR). How do I buy shares of Bio-Rad Laboratories? Shares of BIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (CNSX:BIO) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishingtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
